Docetaxel

מדינה: ניו זילנד

שפה: אנגלית

מקור: Medsafe (Medicines Safety Authority)

מרכיב פעיל:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

זמין מ:

REX Medical Ltd

INN (שם בינלאומי):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

כמות:

80 mg/mL

טופס פרצבטיות:

Concentrate for infusion

הרכב:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

יחידות באריזה:

Vial, glass, Diluent, 6 mL

סיווג:

Prescription

סוג מרשם:

Prescription

תוצרת:

Cipla Ltd

סממני תרפויטית:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

leaflet_short:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

תאריך אישור:

2006-06-23